The subcutaneous tumor size reached 884 mm3 51 days post-graft in the control group, while the FKBP4 shRNA CDX tumor grew much slower, reaching 399 mm3 at day 51 (P<0.01). The gene discussed is FKBP4; the disease is neoplasm.